Serum FGF21 levels were significantly elevated in patients with AMI, coronary artery disease, hypertension, and dilated cardiomyopathy (Gu et al., 2021a, 2021b; Zhang et al., 2021). The gene discussed is FGF21; the disease is coronary artery disorder.